文献速递肺结节与肺癌

靶向肺健康检查中即时远程戒烟干预随机对照试验

Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health Check: Quit Smoking Lung Health Intervention Trial, a Randomized Controlled Trial.
PubMed 文献 · Chest · 2022-08-04

结论认为在靶向肺筛查背景下提供包含药物治疗的即时强化电话戒烟干预与3个月戒烟率升高相关。

要点

  • 即时电话戒烟干预组3个月自报7天点戒烟率为21.1%,显著高于常规护理组的8.9%。
  • 干预效果不受基线吸烟特征或低剂量CT发现异常的影响。
  • 靶向肺健康检查是实施即时远程戒烟干预的有效场景。

核心结论

  • 在靶向肺筛查背景下,即时提供包含药物治疗的强化电话戒烟干预与3个月时戒烟率升高相关。

主要发现

  • 控制人口学特征后,基线吸烟特征或低剂量CT发现异常均未改变干预效果。

关键数值与推荐

  • 主要结局为3个月时自报7天点戒烟率。
  • 干预组接受即时电话戒烟支持(开始即启动并持续6周)及适当药物治疗;常规护理组接受极简戒烟建议并转介至戒烟服务。

临床怎么用

  • 在靶向肺健康检查中可考虑为吸烟者即时提供电话戒烟干预联合药物治疗以提高戒烟率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lung cancer screening programs provide an opportunity to support people who smoke to quit, but the most appropriate model for delivery remains to be determined. Immediate face-to-face smoking cessation support for people undergoing screening can increase quit rates, but it is not known whether remote delivery of immediate smoking cessation counselling and pharmacotherapy in this context also is effective. RESEARCH QUESTION: Does an immediate telephone smoking cessation intervention increase quit rates compared with usual care among a population enrolled in a targeted lung health check (TLHC)? STUDY DESIGN AND METHODS: In a single-masked randomized controlled trial, people 55 to 75 years of age who smoke and attended a TLHC were allocated by day of attendance to receive either immediate telephone smoking cessation intervention (TSI) support (starting immediately and lasting for 6 weeks) with appropriate pharmacotherapy or usual care (UC; very brief advice to quit and signposting to smoking cessation services). The primary outcome was self-reported 7-day point prevalence smoking abstinence at 3 months. Differences between groups were assessed using logistic regression. RESULTS: Three hundred fifteen people taking part in the screening program who reported current smoking with a mean ± SD age of 63 ± 5.4 years, 48% of whom were women, were randomized to TSI (n = 152) or UC (n = 163). The two groups were well matched at baseline. Self-reported quit rates were higher in the intervention arm, 21.1% vs 8.9% (OR, 2.83; 95% CI, 1.44-5.61; P = .002). Controlling for participant demographics, neither baseline smoking characteristics nor the discovery of abnormalities on low-dose CT imaging modified the effect of the intervention. INTERPRETATION: Immediate provision of an intensive telephone-based smoking cessation intervention including pharmacotherapy, delivered within a targeted lung screening context, is associated with increased smoking abstinence at 3 months. TRIAL REGISTRY: ISRCTN registry; No.: ISRCTN12455871; URL: www.IRSCN.com.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Williams PJ, Philip KEJ, Gill NK, et al. Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health Check: Quit Smoking Lung Health Intervention Trial, a Randomized Controlled Trial. Chest. 2022. PMID: 35932889. doi:10.1016/j.chest.2022.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。